{"generic":"Alcaftadine","drugs":["Alcaftadine","Lastacaft"],"mono":{"0":{"id":"jxc9s0","title":"Generic Names","mono":"Alcaftadine"},"1":{"id":"jxc9s1","title":"Dosing and Indications","sub":{"0":{"id":"jxc9s1b4","title":"Adult Dosing","mono":"<b>Allergic conjunctivitis - Itching; Prophylaxis:<\/b> Instill 1 drop of 0.25% OPHTHALMIC solution into each eye once daily "},"1":{"id":"jxc9s1b5","title":"Pediatric Dosing","mono":"<b>Allergic conjunctivitis - Itching; Prophylaxis:<\/b> (2 years and older) instill 1 drop of 0.25% OPHTHALMIC solution into each eye once daily "},"3":{"id":"jxc9s1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Allergic conjunctivitis - Itching; Prophylaxis<br\/>"}}},"3":{"id":"jxc9s3","title":"Contraindications\/Warnings","sub":[{"id":"jxc9s3b9","title":"Contraindications","mono":"Hypersensitivity to alcaftadine or any component of the product <br\/>"},{"id":"jxc9s3b10","title":"Precautions","mono":"<ul><li>Ophthalmic:<\/li><li>-- Eye injury and contamination of the dropper tip and solution may occur; instruct to not touch eyelids or surrounding areas with dropper tip and close bottle tightly when not in use<\/li><li>-- Red eyes; advise not to wear contact lens<\/li><li>-- Contact lens-related eye irritation; not recommended for use<\/li><li>-- Topical ophthalmic use only<\/li><li>Concomitant Use:<\/li><li>-- Remove contact lenses prior to administration and allow at least 10 minutes before reinserting after use<\/li><\/ul>"},{"id":"jxc9s3b11","title":"Pregnancy Category","mono":"B (FDA)<br\/>"},{"id":"jxc9s3b12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"jxc9s4","title":"Drug Interactions","sub":{"1":{"id":"jxc9s4b14","title":"Major","mono":"<ul><li>Bupropion (theoretical)<\/li><li>Donepezil (theoretical)<\/li><\/ul>"}}},"5":{"id":"jxc9s5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Neurologic:<\/b>Headache (Less than 3%)<\/li><li><b>Ophthalmic:<\/b>Burning sensation in eye (Less than 4%), Eye irritation (Less than 4%), Itching of eye (Less than 4%), Red eye (Less than 4%)<\/li><\/ul>"},"6":{"id":"jxc9s6","title":"Drug Name Info","sub":{"0":{"id":"jxc9s6b17","title":"US Trade Names","mono":"Lastacaft<br\/>"},"2":{"id":"jxc9s6b19","title":"Class","mono":"<ul><li>Antihistamine<\/li><li>Ophthalmologic Agent<\/li><\/ul>"},"3":{"id":"jxc9s6b20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"jxc9s6b21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"jxc9s7","title":"Mechanism Of Action","mono":"Alcaftadine is an H1 histamine receptor antagonist which inhibits the histamine release from mast cells.<br\/>"},"8":{"id":"jxc9s8","title":"Pharmacokinetics","sub":{"1":{"id":"jxc9s8b24","title":"Distribution","mono":"Protein binding: 39.2%, alcaftadine; 62.7%, carboxylic acid metabolite <br\/>"},"2":{"id":"jxc9s8b25","title":"Metabolism","mono":"<ul><li>Hepatic: via non-CYP450 cytosolic enzymes<\/li><li>carboxylic acid metabolite: active<\/li><\/ul>"},"3":{"id":"jxc9s8b26","title":"Excretion","mono":"Renal: carboxylic acid metabolite mainly excreted unchanged in the urine (oral data) <br\/>"},"4":{"id":"jxc9s8b27","title":"Elimination Half Life","mono":"carboxylic acid metabolite: 2 hours <br\/>"}}},"9":{"id":"jxc9s9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>For topical ophthalmic use only<br\/><\/li><li><b>Ophthalmic<\/b><br\/><ul><li>Remove contact lenses prior to instillation of drops; may reinsert lenses 10 minutes after instillation.<\/li><li>Administer concomitant ophthalmic drugs at least 5 minutes apart.<\/li><\/ul><\/li><\/ul>"},"10":{"id":"jxc9s10","title":"Monitoring","mono":"absence of ocular itching associated with allergic conjunctivitis is indicative of efficacy<br\/>"},"11":{"id":"jxc9s11","title":"How Supplied","mono":"<b>Lastacaft<\/b><br\/>Ophthalmic Solution: 2.5 MG\/ML<br\/>"},"13":{"id":"jxc9s13","title":"Clinical Teaching","mono":"<ul><li>Drug may cause nasopharyngitis, headache, and eye redness, pruritus, irritation, burning, and\/or stinging.<\/li><li>Instruct patient on proper instillation technique.<\/li><li>Advise patient to remove contact lenses prior to instilling drug as preservative may be absorbed by soft lenses. Lenses may be reinserted 10 minutes following instillation.<\/li><\/ul>"}}}